-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q4 2022.
- Kinnate Biopharma Inc. Return On Equity for the quarter ending December 31, 2022 was -44.7 %, a 74.2% decline year-over-year.
- Kinnate Biopharma Inc. annual Return On Equity for 2022 was -44.7 %, a 74.2% decline from 2021.
- Kinnate Biopharma Inc. annual Return On Equity for 2021 was -25.6 %, a 45.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)